Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Sell
28,160
-1,833
-6% -$22.8K ﹤0.01% 1367
2026
Q1
$394K Buy
29,993
+6,484
+28% +$114K ﹤0.01% 1123
2025
Q4
$624K Sell
23,509
-4,492
-16% -$122K ﹤0.01% 857
2025
Q3
$841K Buy
28,001
+226
+0.8% +$7.76K 0.01% 769
2025
Q2
$1.17M Buy
27,775
+651
+2% +$23.5K 0.01% 657
2025
Q1
$852K Buy
27,124
+512
+2% +$19.2K 0.01% 751
2024
Q4
$921K Buy
26,612
+1,692
+7% +$49.3K 0.01% 753
2024
Q3
$573K Buy
24,920
+254
+1% +$6.19K 0.01% 895
2024
Q2
$649K Sell
24,666
-2,738
-10% -$65.6K 0.01% 826
2024
Q1
$596K Sell
27,404
-276
-1% -$5.87K 0.01% 896
2023
Q4
$575K Buy
27,680
+237
+0.9% +$4.05K 0.01% 879
2023
Q3
$414K Buy
27,443
+2,451
+10% +$36.4K 0.01% 956
2023
Q2
$332K Sell
24,992
-3,309
-12% -$44.8K ﹤0.01% 1033
2023
Q1
$418K Buy
28,301
+1,258
+5% +$17.9K 0.01% 960
2022
Q4
$301K Buy
27,043
+2,923
+12% +$29.4K ﹤0.01% 1034
2022
Q3
$199K Buy
24,120
+2,863
+13% +$29.8K ﹤0.01% 1087
2022
Q2
$208K Buy
21,257
+1,115
+6% +$13K ﹤0.01% 1086
2022
Q1
$264K Sell
20,142
-369
-2% -$5.55K ﹤0.01% 1048
2021
Q4
$371K Buy
+20,511
New +$443K 0.01% 1003

Other funds holding KD

Xponance's KD Position: Q2 2026 in Review

Xponance reduced its Kyndryl (KD) stake by 6.1% in Q2 2026, selling an estimated $22.8K and leaving 28,160 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Xponance first reported a position in KD in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.17M in Q2 2025. 673 funds tracked by Wall St. Rank hold KD as of Q2 2026.

  • Xponance held 28,160 shares of Kyndryl worth $318K as of Q2 2026.
  • Xponance sold 1,833 Kyndryl shares in Q2 2026, an estimated $22.8K.
  • Kyndryl made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1367 holding.
  • Xponance first reported a position in Kyndryl in Q4 2021 and has held it in 19 quarters since.
  • Xponance's Kyndryl position peaked at $1.17M in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Kyndryl as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.